Bridge City Capital’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,898
Closed -$1.34M 113
2023
Q4
$1.34M Buy
19,898
+3,360
+20% +$234K 0.52% 86
2023
Q3
$1.24M Buy
16,538
+429
+3% +$38.1K 0.63% 77
2023
Q2
$1.48M Buy
16,109
+4,759
+42% +$424K 0.7% 68
2023
Q1
$1.18M Sell
11,350
-46
-0.4% -$5.1K 0.59% 81
2022
Q4
$1.31M Sell
11,396
-80
-0.7% -$9.32K 0.67% 76
2022
Q3
$1.24M Buy
11,476
+351
+3% +$50.3K 0.68% 76
2022
Q2
$2.01M Sell
11,125
-21
-0.2% -$3.76K 1.06% 42
2022
Q1
$1.9M Buy
11,146
+3,125
+39% +$589K 0.89% 54
2021
Q4
$1.68M Hold
8,021
0.69% 72
2021
Q3
$1.54M Sell
8,021
-2,140
-21% -$526K 0.7% 73
2021
Q2
$2.88M Sell
10,161
-338
-3% -$91.6K 0.98% 48
2021
Q1
$2.22M Sell
10,499
-107
-1% -$25.6K 0.74% 72
2020
Q4
$2.08M Sell
10,606
-110
-1% -$19.4K 0.79% 63
2020
Q3
$1.76M Sell
10,716
-5,406
-34% -$890K 0.84% 59
2020
Q2
$2.24M Sell
16,122
-2,500
-13% -$230K 1.03% 50
2020
Q1
$1.16M Buy
+18,622
New +$1.7M 0.56% 78

Other funds holding MED

Bridge City Capital's MED Position: Q1 2024 in Review

Bridge City Capital sold out of Medifast (MED) in Q1 2024, closing a stake of 19,898 shares — an estimated $1.34M sold.

Bridge City Capital first reported a position in MED in Q1 2020 and held it in 16 quarters. The position peaked at $2.88M in Q2 2021. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Bridge City Capital reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Bridge City Capital sold 19,898 Medifast shares in Q1 2024, an estimated $1.34M.
  • Bridge City Capital first reported a position in Medifast in Q1 2020 and held it in 16 quarters.
  • Bridge City Capital's Medifast position peaked at $2.88M in Q2 2021.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Bridge City Capital's 13F filing for Q1 2024, filed 12 Apr 2024.